Nerve function study in Charcot-Marie-Tooth and related neuropathies
Part of Brain & nervous system, Genetic & congenital, Immune system & allergy clinical trials.
This study looks at how nerves work and their structure in people with Charcot-Marie-Tooth disease, CIDP, or anti-MAG neuropathy. It may help doctors better understand these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed genetic diagnosis of a specific type of Charcot-Marie-Tooth disease (CMT), or a clinical diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) or anti-MAG polyneuropathy.
- Your neuropathy should not be caused by other conditions like diabetes, kidney disease, alcohol, or certain medications.
- You cannot have had chemotherapy or other drugs that can damage nerves.
- You cannot have had any cancer (other than skin cancer) in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how Charcot-Marie-Tooth disease (CMT) or related inherited nerve conditions change over time. It may help researchers better understand what to expect and guide future treatments.
This study examines how autonomic nerves (the nerves that control automatic body functions like heart rate and blood pressure) are affected in people with CMT (Charcot-Marie-Tooth disease), a genetic nerve disorder. Understanding this may help improve treatment and quality of life for CMT patients.
This study looks at whether a nerve test result can predict how well patients with anti-MAG neuropathy respond to treatment. It aims to help doctors choose the best therapy for each person.
This study is looking for people with Charcot-Marie-Tooth disease (a nerve condition) and healthy volunteers to track long-term changes in the body. Researchers want to see if certain biomarkers (measurable signs) can help predict how CMT progresses over time.
This study follows people who have Charcot-Marie-Tooth disease (CMT) and compares them with people without nerve disease. The goal is to better understand different CMT types and how symptoms and nerve test results change over time.
This study looks at a treatment made from immune proteins (immunoglobulin M) to treat neuropathy caused by anti-MAG antibodies. It may help improve nerve symptoms in people with this specific type of nerve condition.
Hear when a new Charcot-Marie-Tooth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.